Table 4.
Gene | SNP | Model | OR | 95% CI | p | Full models |
---|---|---|---|---|---|---|
ILIB | rs1143642 | D | 2.37 | 1.21, 4.64 | .012 | χ2=16.5, p=.021 |
ILIB | rs1143623 | A | 0.54 | 0.31, 0.95 | .034 | χ2=15.2, p=.034 |
IL6 | rs4719714 | A | 1.71 | 1.03, 2.85 | .039 | χ2=14.5, p=.044 |
IL13 | rs1295686 | A | 0.59 | 0.36, 0.97 | .037 | χ2=14.8, p=.039 |
NFKB1 | rs4648110 | R | 4.28 | 1.76, 10.44 | .001 | χ2=20.0, p=.006 |
TNFA | rs2857602 | R | 2.57 | 1.09, 6.06 | .030 | χ2=14.7, p=.040 |
Notes. Models predict membership in the group with sleep onset latency >30 minutes, and the group with sleep onset latency ≤30 minutes serves as the reference. All models adjusted for genomic estimates of ancestry, self-reported race/ethnicity, and viral load. The sample size for adjusted analyses was 285 due to missing viral load values for 22 participants. A = additive model; CI = confidence interval; D = dominant model; IL = interleukin; NKFKB = nuclear factor of kappa light polypeptide gene enhancer in B cells; OR = odds ratio based on dose of minor allele; R = recessive model; TNFA = tumor necrosis factor alpha.